Insider Transactions in Q1 2025 at Soleno Therapeutics Inc (SLNO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Patricia C Hirano |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+5.39%
|
-
|
|
Jan 21
2025
|
Michael F. Huang Sr. VP of Clinical Development |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+13.39%
|
-
|
|
Jan 21
2025
|
James H Mackaness CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,500
+10.34%
|
-
|
|
Jan 21
2025
|
Meredith Manning Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,600
+20.24%
|
-
|
|
Jan 21
2025
|
Kristen Yen |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+7.16%
|
-
|
|
Jan 21
2025
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,900
+6.69%
|
-
|
|
Jan 03
2025
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,154
-1.43%
|
$467,084
$46.18 P/Share
|
|
Jan 03
2025
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
1,459
-1.36%
|
$67,114
$46.18 P/Share
|
|
Jan 03
2025
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,791
-3.29%
|
$174,386
$46.18 P/Share
|
|
Jan 03
2025
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
2,340
-2.96%
|
$107,640
$46.18 P/Share
|
|
Jan 02
2025
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,937
-0.76%
|
$492,165
$45.64 P/Share
|
|
Jan 02
2025
|
Patricia C Hirano |
SELL
Open market or private sale
|
Direct |
1,571
-0.72%
|
$70,695
$45.64 P/Share
|
|
Jan 02
2025
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,083
-1.72%
|
$183,735
$45.64 P/Share
|
|
Jan 02
2025
|
Kristen Yen |
SELL
Open market or private sale
|
Direct |
2,520
-1.55%
|
$113,400
$45.64 P/Share
|